Annual Cash & Cash Equivalents
$150.28 M
-$51.73 M-25.61%
December 31, 2023
Summary
- As of February 7, 2025, DVAX annual cash & cash equivalents is $150.28 million, with the most recent change of -$51.73 million (-25.61%) on December 31, 2023.
- During the last 3 years, DVAX annual cash & cash equivalents has risen by +$118.21 million (+368.55%).
- DVAX annual cash & cash equivalents is now -65.55% below its all-time high of $436.19 million, reached on December 31, 2021.
Performance
DVAX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$119.33 M
+$6.83 M+6.07%
September 30, 2024
Summary
- As of February 7, 2025, DVAX quarterly cash and cash equivalents is $119.33 million, with the most recent change of +$6.83 million (+6.07%) on September 30, 2024.
- Over the past year, DVAX quarterly cash and cash equivalents has dropped by -$35.18 million (-22.77%).
- DVAX quarterly cash and cash equivalents is now -72.64% below its all-time high of $436.19 million, reached on December 31, 2021.
Performance
DVAX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DVAX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.6% | -22.8% |
| 3 y3 years | +368.6% | -51.6% |
| 5 y5 years | +204.5% | +219.9% |
DVAX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.5% | at low | -72.6% | +6.1% |
| 5 y | 5-year | -65.5% | +368.6% | -72.6% | +272.1% |
| alltime | all time | -65.5% | +2806.2% | -72.6% | +2232.5% |
Dynavax Technologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $119.33 M(+6.1%) |
| Jun 2024 | - | $112.50 M(-14.8%) |
| Mar 2024 | - | $132.03 M(-12.1%) |
| Dec 2023 | $150.28 M(-25.6%) | $150.28 M(-2.7%) |
| Sep 2023 | - | $154.51 M(-31.9%) |
| Jun 2023 | - | $226.82 M(+30.1%) |
| Mar 2023 | - | $174.35 M(-13.7%) |
| Dec 2022 | $202.00 M(-53.7%) | $202.00 M(+1.7%) |
| Sep 2022 | - | $198.58 M(-20.3%) |
| Jun 2022 | - | $249.09 M(+38.8%) |
| Mar 2022 | - | $179.42 M(-58.9%) |
| Dec 2021 | $436.19 M(+1260.0%) | $436.19 M(+77.1%) |
| Sep 2021 | - | $246.35 M(+90.1%) |
| Jun 2021 | - | $129.61 M(+63.9%) |
| Mar 2021 | - | $79.06 M(+146.5%) |
| Dec 2020 | $32.07 M(-19.6%) | $32.07 M(-1.9%) |
| Sep 2020 | - | $32.69 M(-46.0%) |
| Jun 2020 | - | $60.48 M(+59.6%) |
| Mar 2020 | - | $37.90 M(-5.0%) |
| Dec 2019 | $39.88 M(-19.2%) | $39.88 M(+6.9%) |
| Sep 2019 | - | $37.30 M(+9.0%) |
| Jun 2019 | - | $34.23 M(-69.5%) |
| Mar 2019 | - | $112.13 M(+127.2%) |
| Dec 2018 | $49.35 M(+85.6%) | $49.35 M(+27.5%) |
| Sep 2018 | - | $38.71 M(+34.8%) |
| Jun 2018 | - | $28.73 M(-20.4%) |
| Mar 2018 | - | $36.07 M(+35.7%) |
| Dec 2017 | $26.58 M(+9.4%) | $26.58 M(+32.3%) |
| Sep 2017 | - | $20.10 M(-46.7%) |
| Jun 2017 | - | $37.67 M(+75.5%) |
| Mar 2017 | - | $21.47 M(-11.6%) |
| Dec 2016 | $24.29 M(-45.8%) | $24.29 M(+5.5%) |
| Sep 2016 | - | $23.02 M(-7.1%) |
| Jun 2016 | - | $24.79 M(-36.2%) |
| Mar 2016 | - | $38.86 M(-13.3%) |
| Dec 2015 | $44.81 M(-9.5%) | $44.81 M(-56.5%) |
| Sep 2015 | - | $103.03 M(+182.4%) |
| Jun 2015 | - | $36.49 M(+148.0%) |
| Mar 2015 | - | $14.71 M(-70.3%) |
| Dec 2014 | $49.51 M | $49.51 M(+151.9%) |
| Sep 2014 | - | $19.66 M(+15.4%) |
| Jun 2014 | - | $17.03 M(-36.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $26.75 M(+15.7%) |
| Dec 2013 | $23.12 M(+204.3%) | $23.12 M(+89.7%) |
| Sep 2013 | - | $12.19 M(-30.7%) |
| Jun 2013 | - | $17.59 M(-29.7%) |
| Mar 2013 | - | $25.02 M(+229.2%) |
| Dec 2012 | $7.60 M(-76.2%) | $7.60 M(-69.2%) |
| Sep 2012 | - | $24.65 M(-28.6%) |
| Jun 2012 | - | $34.53 M(+74.8%) |
| Mar 2012 | - | $19.75 M(-38.2%) |
| Dec 2011 | $31.94 M(+42.3%) | $31.94 M(+67.5%) |
| Sep 2011 | - | $19.07 M(-30.6%) |
| Jun 2011 | - | $27.48 M(+31.0%) |
| Mar 2011 | - | $20.97 M(-6.6%) |
| Dec 2010 | $22.45 M(-38.9%) | $22.45 M(-20.4%) |
| Sep 2010 | - | $28.21 M(-2.9%) |
| Jun 2010 | - | $29.05 M(-3.4%) |
| Mar 2010 | - | $30.08 M(-18.1%) |
| Dec 2009 | $36.72 M(+30.7%) | $36.72 M(+48.5%) |
| Sep 2009 | - | $24.73 M(+4.1%) |
| Jun 2009 | - | $23.76 M(+3.7%) |
| Mar 2009 | - | $22.92 M(-18.4%) |
| Dec 2008 | $28.10 M(+96.6%) | $28.10 M(+24.3%) |
| Sep 2008 | - | $22.62 M(+52.1%) |
| Jun 2008 | - | $14.87 M(-6.2%) |
| Mar 2008 | - | $15.86 M(+10.9%) |
| Dec 2007 | $14.29 M(+1.0%) | $14.29 M(-2.4%) |
| Sep 2007 | - | $14.64 M(+125.2%) |
| Jun 2007 | - | $6.50 M(-49.9%) |
| Mar 2007 | - | $12.98 M(-8.3%) |
| Dec 2006 | $14.15 M(+62.2%) | $14.15 M(-11.3%) |
| Sep 2006 | - | $15.95 M(+58.1%) |
| Jun 2006 | - | $10.09 M(-40.1%) |
| Mar 2006 | - | $16.84 M(+93.0%) |
| Dec 2005 | $8.72 M(-47.4%) | $8.72 M(-54.5%) |
| Sep 2005 | - | $19.17 M(+274.7%) |
| Jun 2005 | - | $5.12 M(-55.1%) |
| Mar 2005 | - | $11.40 M(-31.3%) |
| Dec 2004 | $16.59 M(-29.3%) | $16.59 M(-76.8%) |
| Sep 2004 | - | $71.51 M(-3.3%) |
| Jun 2004 | - | $73.96 M(-1.4%) |
| Mar 2004 | - | $75.01 M(+219.6%) |
| Dec 2003 | $23.47 M(+353.8%) | $23.47 M |
| Dec 2002 | $5.17 M | - |
FAQ
- What is Dynavax Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dynavax Technologies?
- What is Dynavax Technologies annual cash & cash equivalents year-on-year change?
- What is Dynavax Technologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dynavax Technologies?
- What is Dynavax Technologies quarterly cash and cash equivalents year-on-year change?
What is Dynavax Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of DVAX is $150.28 M
What is the all time high annual cash & cash equivalents for Dynavax Technologies?
Dynavax Technologies all-time high annual cash & cash equivalents is $436.19 M
What is Dynavax Technologies annual cash & cash equivalents year-on-year change?
Over the past year, DVAX annual cash & cash equivalents has changed by -$51.73 M (-25.61%)
What is Dynavax Technologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DVAX is $119.33 M
What is the all time high quarterly cash and cash equivalents for Dynavax Technologies?
Dynavax Technologies all-time high quarterly cash and cash equivalents is $436.19 M
What is Dynavax Technologies quarterly cash and cash equivalents year-on-year change?
Over the past year, DVAX quarterly cash and cash equivalents has changed by -$35.18 M (-22.77%)